← Leaderboards
Danny N. Dhanasekaran
Temple University
$11,435,300
Attributed
$11,435,300
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,909,188 · 9
By mechanism
P20$27,523,595 · 3
R01$3,860,973 · 3
P30$3,194,620 · 2
R21$330,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProgramsResearch PersonnelPilot ProjectsFundingMentorsUnited States National Institutes Of HealthCenters Of Research ExcellenceOklahomaGrantCancer CenterBaseCessation Of LifeCancer BurdenUniversitiesResearch InfrastructureCommunitiesHealth SciencesAccountingPlayCollaborationsStructureAnticancer ResearchFight Against
Grant awards (43)
Mentoring Translational Cancer Research in Oklahoma$1,072,500
P30 · FY2025 · GM · contact PI
Admin Core$524,810
P30 · FY2025 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$1,072,500
P30 · FY2024 · GM · contact PI
Admin Core$524,810
P30 · FY2024 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,134,482
P20 · FY2022 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$598,103
P20 · FY2022 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,149,166
P20 · FY2021 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$664,544
P20 · FY2021 · GM · contact PI
Administrative Supplement to acquire Applied Biosystems 3500XL Genetic Analyzer for the COBRE Core$216,112
P20 · FY2021 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,165,736
P20 · FY2020 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$659,413
P20 · FY2020 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,170,256
P20 · FY2019 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$659,413
P20 · FY2019 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,174,663
P20 · FY2018 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$659,413
P20 · FY2018 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,030,950
P20 · FY2016 · GM · contact PI
Administration and Mentoring Module$592,093
P20 · FY2016 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,058,066
P20 · FY2015 · GM · contact PI
Administration and Mentoring Module$592,091
P20 · FY2015 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,083,290
P20 · FY2014 · GM · contact PI
Administration and Mentoring Module$592,092
P20 · FY2014 · GM · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,035,795
P20 · FY2013 · GM · contact PI
Administration and Mentoring Module$582,862
P20 · FY2013 · GM · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$226,812
R01 · FY2013 · CA · contact PI
Mentoring Translational Cancer Research in Oklahoma$2,110,372
P20 · FY2012 · GM · contact PI
Administration and Mentoring Module$594,683
P20 · FY2012 · GM · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$241,288
R01 · FY2012 · CA · contact PI
G Proteins and Their Receptors in Tumor Cell Metastasis$289,351
R01 · FY2011 · CA · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$1
R01 · FY2011 · CA · contact PI
G Proteins and Their Receptors in Tumor Cell Metastasis$300,580
R01 · FY2010 · CA · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$248,751
R01 · FY2010 · CA · contact PI
G Proteins and Their Receptors in Tumor Cell Metastasis$305,220
R01 · FY2009 · CA · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$280,125
R01 · FY2009 · CA · contact PI
G Proteins and Their Receptors in Tumor Cell Metastasis$302,815
R01 · FY2008 · CA · contact PI
Regulation of JNK-signaling molecules by the gep oncogenes$280,125
R01 · FY2008 · CA · contact PI
G-Protein Signaling in Pancreatic Cancer$118,057
R21 · FY2008 · CA · contact PI
G-Protein Signaling in Pancreatic Cancer$91,943
R21 · FY2008 · CA · contact PI
G Proteins and Their Receptors in Tumor Cell Metastasis$302,305
R01 · FY2007 · CA · contact PI
G-Protein Signaling in Pancreatic Cancer$120,000
R21 · FY2007 · CA · contact PI
Functional analysis of G alpha 12/G alpha 13 G-proteins$270,900
R01 · FY2004 · GM
Functional analysis of G alpha 12/G alpha 13 G-proteins$270,900
R01 · FY2003 · GM
Functional analysis of G alpha 12/G alpha 13 G-proteins$270,900
R01 · FY2002 · GM
Functional analysis of G alpha 12/G alpha 13 G-proteins$270,900
R01 · FY2001 · GM